nodes	percent_of_prediction	percent_of_DWPC	metapath
Sildenafil—CYP1A1—kidney cancer	0.203	1	CbGaD
Sildenafil—ABCC10—Gemcitabine—kidney cancer	0.0601	0.111	CbGbCtD
Sildenafil—ABCC10—Paclitaxel—kidney cancer	0.0543	0.1	CbGbCtD
Sildenafil—ABCC10—Vincristine—kidney cancer	0.0468	0.0863	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.0302	0.0556	CbGbCtD
Sildenafil—CYP3A7—Temsirolimus—kidney cancer	0.0302	0.0556	CbGbCtD
Sildenafil—ABCC10—Doxorubicin—kidney cancer	0.0292	0.0539	CbGbCtD
Sildenafil—ABCC4—Sorafenib—kidney cancer	0.0232	0.0427	CbGbCtD
Sildenafil—CYP3A5—Temsirolimus—kidney cancer	0.0226	0.0417	CbGbCtD
Sildenafil—ABCC4—Sunitinib—kidney cancer	0.0188	0.0346	CbGbCtD
Sildenafil—CYP1A1—Erlotinib—kidney cancer	0.0141	0.0261	CbGbCtD
Sildenafil—CYP2D6—Temsirolimus—kidney cancer	0.0139	0.0256	CbGbCtD
Sildenafil—CYP3A4—Everolimus—kidney cancer	0.0131	0.0241	CbGbCtD
Sildenafil—CYP3A7—Paclitaxel—kidney cancer	0.0104	0.0191	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.0104	0.0191	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.0092	0.017	CbGbCtD
Sildenafil—CYP3A7—Sorafenib—kidney cancer	0.0092	0.017	CbGbCtD
Sildenafil—CYP3A7—Vincristine—kidney cancer	0.00893	0.0165	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.00893	0.0165	CbGbCtD
Sildenafil—CYP3A4—Temsirolimus—kidney cancer	0.00883	0.0163	CbGbCtD
Sildenafil—CYP3A5—Erlotinib—kidney cancer	0.00848	0.0156	CbGbCtD
Sildenafil—CYP2C9—Capecitabine—kidney cancer	0.00832	0.0153	CbGbCtD
Sildenafil—CYP3A5—Paclitaxel—kidney cancer	0.00777	0.0143	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.00745	0.0137	CbGbCtD
Sildenafil—CYP3A7—Sunitinib—kidney cancer	0.00745	0.0137	CbGbCtD
Sildenafil—CYP2D6—Pazopanib—kidney cancer	0.00729	0.0134	CbGbCtD
Sildenafil—CYP3A5—Sorafenib—kidney cancer	0.0069	0.0127	CbGbCtD
Sildenafil—CYP3A5—Vincristine—kidney cancer	0.0067	0.0124	CbGbCtD
Sildenafil—CYP3A5—Sunitinib—kidney cancer	0.00559	0.0103	CbGbCtD
Sildenafil—CYP2C19—Sorafenib—kidney cancer	0.00556	0.0103	CbGbCtD
Sildenafil—CYP2C9—Paclitaxel—kidney cancer	0.00521	0.00961	CbGbCtD
Sildenafil—CYP2D6—Erlotinib—kidney cancer	0.0052	0.00959	CbGbCtD
Sildenafil—CYP3A4—Pazopanib—kidney cancer	0.00464	0.00855	CbGbCtD
Sildenafil—CYP2C9—Sorafenib—kidney cancer	0.00463	0.00853	CbGbCtD
Sildenafil—CYP2D6—Sorafenib—kidney cancer	0.00423	0.0078	CbGbCtD
Sildenafil—CYP2D6—Vinblastine—kidney cancer	0.00418	0.0077	CbGbCtD
Sildenafil—CYP3A4—Erlotinib—kidney cancer	0.00331	0.0061	CbGbCtD
Sildenafil—CYP3A4—Paclitaxel—kidney cancer	0.00303	0.00559	CbGbCtD
Sildenafil—CYP3A4—Sorafenib—kidney cancer	0.00269	0.00496	CbGbCtD
Sildenafil—CYP3A4—Vinblastine—kidney cancer	0.00266	0.0049	CbGbCtD
Sildenafil—CYP3A4—Vincristine—kidney cancer	0.00261	0.00482	CbGbCtD
Sildenafil—CYP2D6—Doxorubicin—kidney cancer	0.00257	0.00473	CbGbCtD
Sildenafil—CYP3A4—Sunitinib—kidney cancer	0.00218	0.00402	CbGbCtD
Sildenafil—CYP2C19—urine—kidney cancer	0.00197	0.0814	CbGeAlD
Sildenafil—CYP3A4—Doxorubicin—kidney cancer	0.00163	0.00301	CbGbCtD
Sildenafil—CYP2C9—urine—kidney cancer	0.00152	0.0631	CbGeAlD
Sildenafil—CYP2E1—urine—kidney cancer	0.00144	0.0598	CbGeAlD
Sildenafil—CYP3A4—urine—kidney cancer	0.00116	0.0481	CbGeAlD
Sildenafil—CYP2D6—urine—kidney cancer	0.00114	0.0473	CbGeAlD
Sildenafil—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.00101	0.0417	CbGeAlD
Sildenafil—ABCC5—nephron tubule—kidney cancer	0.000918	0.038	CbGeAlD
Sildenafil—PDE5A—renal system—kidney cancer	0.000912	0.0378	CbGeAlD
Sildenafil—ADORA2A—gonad—kidney cancer	0.000898	0.0372	CbGeAlD
Sildenafil—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.000862	0.0357	CbGeAlD
Sildenafil—PDE5A—gonad—kidney cancer	0.000818	0.0339	CbGeAlD
Sildenafil—ABCC5—cardiac atrium—kidney cancer	0.000747	0.0309	CbGeAlD
Sildenafil—ABCC10—renal system—kidney cancer	0.000697	0.0289	CbGeAlD
Sildenafil—ABCC10—kidney—kidney cancer	0.000674	0.0279	CbGeAlD
Sildenafil—ABCC10—cortex of kidney—kidney cancer	0.000657	0.0272	CbGeAlD
Sildenafil—ABCC4—nephron tubule—kidney cancer	0.000636	0.0263	CbGeAlD
Sildenafil—ABCC10—gonad—kidney cancer	0.000625	0.0259	CbGeAlD
Sildenafil—ABCC10—cardiac atrium—kidney cancer	0.000625	0.0258	CbGeAlD
Sildenafil—ABCC4—renal system—kidney cancer	0.000578	0.0239	CbGeAlD
Sildenafil—ABCC4—kidney—kidney cancer	0.000559	0.0231	CbGeAlD
Sildenafil—ABCC4—cortex of kidney—kidney cancer	0.000545	0.0225	CbGeAlD
Sildenafil—CYP3A5—nephron tubule—kidney cancer	0.000417	0.0173	CbGeAlD
Sildenafil—CYP2E1—nephron tubule—kidney cancer	0.000389	0.0161	CbGeAlD
Sildenafil—CYP1A1—renal system—kidney cancer	0.000388	0.016	CbGeAlD
Sildenafil—CYP3A5—renal system—kidney cancer	0.000379	0.0157	CbGeAlD
Sildenafil—CYP1A1—kidney—kidney cancer	0.000375	0.0155	CbGeAlD
Sildenafil—CYP3A5—kidney—kidney cancer	0.000366	0.0152	CbGeAlD
Sildenafil—CYP3A5—cortex of kidney—kidney cancer	0.000357	0.0148	CbGeAlD
Sildenafil—CYP2E1—renal system—kidney cancer	0.000354	0.0146	CbGeAlD
Sildenafil—CYP1A1—cardiac atrium—kidney cancer	0.000347	0.0144	CbGeAlD
Sildenafil—CYP2E1—kidney—kidney cancer	0.000342	0.0141	CbGeAlD
Sildenafil—CYP2E1—cortex of kidney—kidney cancer	0.000333	0.0138	CbGeAlD
Sildenafil—CYP3A4—renal system—kidney cancer	0.000284	0.0118	CbGeAlD
Sildenafil—CYP2D6—renal system—kidney cancer	0.00028	0.0116	CbGeAlD
Sildenafil—CYP3A4—kidney—kidney cancer	0.000275	0.0114	CbGeAlD
Sildenafil—CYP2D6—kidney—kidney cancer	0.000271	0.0112	CbGeAlD
Sildenafil—Dry mouth—Paclitaxel—kidney cancer	5.15e-05	0.000284	CcSEcCtD
Sildenafil—Diarrhoea—Sunitinib—kidney cancer	5.14e-05	0.000284	CcSEcCtD
Sildenafil—Ataxia—Doxorubicin—kidney cancer	5.1e-05	0.000282	CcSEcCtD
Sildenafil—Mental disorder—Capecitabine—kidney cancer	5.1e-05	0.000282	CcSEcCtD
Sildenafil—Asthenia—Dactinomycin—kidney cancer	5.1e-05	0.000282	CcSEcCtD
Sildenafil—Malnutrition—Capecitabine—kidney cancer	5.07e-05	0.00028	CcSEcCtD
Sildenafil—Erythema—Capecitabine—kidney cancer	5.07e-05	0.00028	CcSEcCtD
Sildenafil—Oedema—Paclitaxel—kidney cancer	5.04e-05	0.000279	CcSEcCtD
Sildenafil—Body temperature increased—Vincristine—kidney cancer	5.02e-05	0.000277	CcSEcCtD
Sildenafil—Abdominal pain—Vincristine—kidney cancer	5.02e-05	0.000277	CcSEcCtD
Sildenafil—Liver function test abnormal—Doxorubicin—kidney cancer	5.01e-05	0.000277	CcSEcCtD
Sildenafil—Infection—Paclitaxel—kidney cancer	5.01e-05	0.000277	CcSEcCtD
Sildenafil—Flatulence—Capecitabine—kidney cancer	5e-05	0.000276	CcSEcCtD
Sildenafil—Dizziness—Sunitinib—kidney cancer	4.96e-05	0.000274	CcSEcCtD
Sildenafil—Feeling abnormal—Gemcitabine—kidney cancer	4.96e-05	0.000274	CcSEcCtD
Sildenafil—Shock—Paclitaxel—kidney cancer	4.96e-05	0.000274	CcSEcCtD
Sildenafil—Vomiting—Sorafenib—kidney cancer	4.96e-05	0.000274	CcSEcCtD
Sildenafil—Orthostatic hypotension—Doxorubicin—kidney cancer	4.96e-05	0.000274	CcSEcCtD
Sildenafil—Abdominal pain upper—Doxorubicin—kidney cancer	4.96e-05	0.000274	CcSEcCtD
Sildenafil—Nervous system disorder—Paclitaxel—kidney cancer	4.95e-05	0.000273	CcSEcCtD
Sildenafil—Hypokalaemia—Doxorubicin—kidney cancer	4.94e-05	0.000273	CcSEcCtD
Sildenafil—Tachycardia—Paclitaxel—kidney cancer	4.92e-05	0.000272	CcSEcCtD
Sildenafil—Rash—Sorafenib—kidney cancer	4.92e-05	0.000272	CcSEcCtD
Sildenafil—Dermatitis—Sorafenib—kidney cancer	4.91e-05	0.000272	CcSEcCtD
Sildenafil—Back pain—Capecitabine—kidney cancer	4.91e-05	0.000271	CcSEcCtD
Sildenafil—Breast disorder—Doxorubicin—kidney cancer	4.91e-05	0.000271	CcSEcCtD
Sildenafil—Skin disorder—Paclitaxel—kidney cancer	4.9e-05	0.000271	CcSEcCtD
Sildenafil—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	4.89e-05	0.00027	CcSEcCtD
Sildenafil—Headache—Sorafenib—kidney cancer	4.89e-05	0.00027	CcSEcCtD
Sildenafil—Hyperhidrosis—Paclitaxel—kidney cancer	4.88e-05	0.000269	CcSEcCtD
Sildenafil—Diarrhoea—Dactinomycin—kidney cancer	4.86e-05	0.000269	CcSEcCtD
Sildenafil—Nasopharyngitis—Doxorubicin—kidney cancer	4.85e-05	0.000268	CcSEcCtD
Sildenafil—Anorexia—Paclitaxel—kidney cancer	4.81e-05	0.000266	CcSEcCtD
Sildenafil—Gastritis—Doxorubicin—kidney cancer	4.8e-05	0.000265	CcSEcCtD
Sildenafil—Alanine aminotransferase increased—Doxorubicin—kidney cancer	4.79e-05	0.000265	CcSEcCtD
Sildenafil—Muscular weakness—Doxorubicin—kidney cancer	4.79e-05	0.000265	CcSEcCtD
Sildenafil—Vision blurred—Capecitabine—kidney cancer	4.78e-05	0.000264	CcSEcCtD
Sildenafil—Vomiting—Sunitinib—kidney cancer	4.77e-05	0.000264	CcSEcCtD
Sildenafil—Body temperature increased—Gemcitabine—kidney cancer	4.76e-05	0.000263	CcSEcCtD
Sildenafil—Tremor—Capecitabine—kidney cancer	4.75e-05	0.000263	CcSEcCtD
Sildenafil—Rash—Sunitinib—kidney cancer	4.73e-05	0.000262	CcSEcCtD
Sildenafil—Dermatitis—Sunitinib—kidney cancer	4.73e-05	0.000261	CcSEcCtD
Sildenafil—Abdominal distension—Doxorubicin—kidney cancer	4.72e-05	0.000261	CcSEcCtD
Sildenafil—Hypotension—Paclitaxel—kidney cancer	4.71e-05	0.00026	CcSEcCtD
Sildenafil—Ill-defined disorder—Capecitabine—kidney cancer	4.71e-05	0.00026	CcSEcCtD
Sildenafil—Headache—Sunitinib—kidney cancer	4.7e-05	0.00026	CcSEcCtD
Sildenafil—Asthma—Doxorubicin—kidney cancer	4.69e-05	0.000259	CcSEcCtD
Sildenafil—Dysphagia—Doxorubicin—kidney cancer	4.69e-05	0.000259	CcSEcCtD
Sildenafil—Influenza—Doxorubicin—kidney cancer	4.69e-05	0.000259	CcSEcCtD
Sildenafil—Anaemia—Capecitabine—kidney cancer	4.69e-05	0.000259	CcSEcCtD
Sildenafil—Hypersensitivity—Vincristine—kidney cancer	4.68e-05	0.000258	CcSEcCtD
Sildenafil—Nausea—Sorafenib—kidney cancer	4.63e-05	0.000256	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Paclitaxel—kidney cancer	4.59e-05	0.000254	CcSEcCtD
Sildenafil—Malaise—Capecitabine—kidney cancer	4.57e-05	0.000253	CcSEcCtD
Sildenafil—Angina pectoris—Doxorubicin—kidney cancer	4.57e-05	0.000252	CcSEcCtD
Sildenafil—Insomnia—Paclitaxel—kidney cancer	4.56e-05	0.000252	CcSEcCtD
Sildenafil—Vertigo—Capecitabine—kidney cancer	4.56e-05	0.000252	CcSEcCtD
Sildenafil—Asthenia—Vincristine—kidney cancer	4.56e-05	0.000252	CcSEcCtD
Sildenafil—Syncope—Capecitabine—kidney cancer	4.55e-05	0.000251	CcSEcCtD
Sildenafil—Leukopenia—Capecitabine—kidney cancer	4.54e-05	0.000251	CcSEcCtD
Sildenafil—Paraesthesia—Paclitaxel—kidney cancer	4.53e-05	0.00025	CcSEcCtD
Sildenafil—Vomiting—Dactinomycin—kidney cancer	4.52e-05	0.00025	CcSEcCtD
Sildenafil—Bronchitis—Doxorubicin—kidney cancer	4.51e-05	0.000249	CcSEcCtD
Sildenafil—Dyspnoea—Paclitaxel—kidney cancer	4.5e-05	0.000248	CcSEcCtD
Sildenafil—Somnolence—Paclitaxel—kidney cancer	4.48e-05	0.000248	CcSEcCtD
Sildenafil—Palpitations—Capecitabine—kidney cancer	4.48e-05	0.000248	CcSEcCtD
Sildenafil—Rash—Dactinomycin—kidney cancer	4.48e-05	0.000248	CcSEcCtD
Sildenafil—Nausea—Sunitinib—kidney cancer	4.46e-05	0.000246	CcSEcCtD
Sildenafil—Loss of consciousness—Capecitabine—kidney cancer	4.46e-05	0.000246	CcSEcCtD
Sildenafil—Dyspepsia—Paclitaxel—kidney cancer	4.44e-05	0.000245	CcSEcCtD
Sildenafil—Cough—Capecitabine—kidney cancer	4.43e-05	0.000244	CcSEcCtD
Sildenafil—Decreased appetite—Paclitaxel—kidney cancer	4.38e-05	0.000242	CcSEcCtD
Sildenafil—Hypertension—Capecitabine—kidney cancer	4.38e-05	0.000242	CcSEcCtD
Sildenafil—Upper respiratory tract infection—Doxorubicin—kidney cancer	4.36e-05	0.000241	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Paclitaxel—kidney cancer	4.35e-05	0.000241	CcSEcCtD
Sildenafil—Fatigue—Paclitaxel—kidney cancer	4.35e-05	0.00024	CcSEcCtD
Sildenafil—Diarrhoea—Vincristine—kidney cancer	4.34e-05	0.00024	CcSEcCtD
Sildenafil—Pollakiuria—Doxorubicin—kidney cancer	4.33e-05	0.000239	CcSEcCtD
Sildenafil—Asthenia—Gemcitabine—kidney cancer	4.32e-05	0.000239	CcSEcCtD
Sildenafil—Arthralgia—Capecitabine—kidney cancer	4.32e-05	0.000239	CcSEcCtD
Sildenafil—Chest pain—Capecitabine—kidney cancer	4.32e-05	0.000239	CcSEcCtD
Sildenafil—Myalgia—Capecitabine—kidney cancer	4.32e-05	0.000239	CcSEcCtD
Sildenafil—Constipation—Paclitaxel—kidney cancer	4.31e-05	0.000238	CcSEcCtD
Sildenafil—Pain—Paclitaxel—kidney cancer	4.31e-05	0.000238	CcSEcCtD
Sildenafil—Anxiety—Capecitabine—kidney cancer	4.3e-05	0.000238	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	4.29e-05	0.000237	CcSEcCtD
Sildenafil—Photosensitivity reaction—Doxorubicin—kidney cancer	4.28e-05	0.000237	CcSEcCtD
Sildenafil—Weight increased—Doxorubicin—kidney cancer	4.27e-05	0.000236	CcSEcCtD
Sildenafil—Discomfort—Capecitabine—kidney cancer	4.27e-05	0.000236	CcSEcCtD
Sildenafil—Pruritus—Gemcitabine—kidney cancer	4.26e-05	0.000235	CcSEcCtD
Sildenafil—Hyperglycaemia—Doxorubicin—kidney cancer	4.23e-05	0.000234	CcSEcCtD
Sildenafil—Dry mouth—Capecitabine—kidney cancer	4.22e-05	0.000233	CcSEcCtD
Sildenafil—Nausea—Dactinomycin—kidney cancer	4.22e-05	0.000233	CcSEcCtD
Sildenafil—Pneumonia—Doxorubicin—kidney cancer	4.21e-05	0.000232	CcSEcCtD
Sildenafil—Dizziness—Vincristine—kidney cancer	4.2e-05	0.000232	CcSEcCtD
Sildenafil—Infestation—Doxorubicin—kidney cancer	4.18e-05	0.000231	CcSEcCtD
Sildenafil—Infestation NOS—Doxorubicin—kidney cancer	4.18e-05	0.000231	CcSEcCtD
Sildenafil—Feeling abnormal—Paclitaxel—kidney cancer	4.16e-05	0.00023	CcSEcCtD
Sildenafil—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	4.15e-05	0.000229	CcSEcCtD
Sildenafil—Oedema—Capecitabine—kidney cancer	4.14e-05	0.000229	CcSEcCtD
Sildenafil—Gastrointestinal pain—Paclitaxel—kidney cancer	4.12e-05	0.000228	CcSEcCtD
Sildenafil—Diarrhoea—Gemcitabine—kidney cancer	4.12e-05	0.000228	CcSEcCtD
Sildenafil—Renal failure—Doxorubicin—kidney cancer	4.11e-05	0.000227	CcSEcCtD
Sildenafil—Infection—Capecitabine—kidney cancer	4.11e-05	0.000227	CcSEcCtD
Sildenafil—Neuropathy peripheral—Doxorubicin—kidney cancer	4.1e-05	0.000227	CcSEcCtD
Sildenafil—Stomatitis—Doxorubicin—kidney cancer	4.08e-05	0.000225	CcSEcCtD
Sildenafil—Shock—Capecitabine—kidney cancer	4.07e-05	0.000225	CcSEcCtD
Sildenafil—Urinary tract infection—Doxorubicin—kidney cancer	4.07e-05	0.000225	CcSEcCtD
Sildenafil—Conjunctivitis—Doxorubicin—kidney cancer	4.07e-05	0.000225	CcSEcCtD
Sildenafil—Nervous system disorder—Capecitabine—kidney cancer	4.06e-05	0.000224	CcSEcCtD
Sildenafil—Tachycardia—Capecitabine—kidney cancer	4.04e-05	0.000223	CcSEcCtD
Sildenafil—Vomiting—Vincristine—kidney cancer	4.04e-05	0.000223	CcSEcCtD
Sildenafil—Skin disorder—Capecitabine—kidney cancer	4.02e-05	0.000222	CcSEcCtD
Sildenafil—Sweating—Doxorubicin—kidney cancer	4.01e-05	0.000222	CcSEcCtD
Sildenafil—Urticaria—Paclitaxel—kidney cancer	4.01e-05	0.000221	CcSEcCtD
Sildenafil—Rash—Vincristine—kidney cancer	4e-05	0.000221	CcSEcCtD
Sildenafil—Hyperhidrosis—Capecitabine—kidney cancer	4e-05	0.000221	CcSEcCtD
Sildenafil—Dermatitis—Vincristine—kidney cancer	4e-05	0.000221	CcSEcCtD
Sildenafil—Haematuria—Doxorubicin—kidney cancer	3.99e-05	0.00022	CcSEcCtD
Sildenafil—Abdominal pain—Paclitaxel—kidney cancer	3.99e-05	0.00022	CcSEcCtD
Sildenafil—Body temperature increased—Paclitaxel—kidney cancer	3.99e-05	0.00022	CcSEcCtD
Sildenafil—Headache—Vincristine—kidney cancer	3.98e-05	0.00022	CcSEcCtD
Sildenafil—Epistaxis—Doxorubicin—kidney cancer	3.95e-05	0.000218	CcSEcCtD
Sildenafil—Anorexia—Capecitabine—kidney cancer	3.95e-05	0.000218	CcSEcCtD
Sildenafil—Sinusitis—Doxorubicin—kidney cancer	3.92e-05	0.000217	CcSEcCtD
Sildenafil—Hypotension—Capecitabine—kidney cancer	3.87e-05	0.000214	CcSEcCtD
Sildenafil—Vomiting—Gemcitabine—kidney cancer	3.83e-05	0.000212	CcSEcCtD
Sildenafil—Rash—Gemcitabine—kidney cancer	3.8e-05	0.00021	CcSEcCtD
Sildenafil—Dermatitis—Gemcitabine—kidney cancer	3.79e-05	0.00021	CcSEcCtD
Sildenafil—Haemoglobin—Doxorubicin—kidney cancer	3.77e-05	0.000209	CcSEcCtD
Sildenafil—Headache—Gemcitabine—kidney cancer	3.77e-05	0.000208	CcSEcCtD
Sildenafil—Nausea—Vincristine—kidney cancer	3.77e-05	0.000208	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Capecitabine—kidney cancer	3.77e-05	0.000208	CcSEcCtD
Sildenafil—Rhinitis—Doxorubicin—kidney cancer	3.76e-05	0.000208	CcSEcCtD
Sildenafil—Haemorrhage—Doxorubicin—kidney cancer	3.76e-05	0.000207	CcSEcCtD
Sildenafil—Insomnia—Capecitabine—kidney cancer	3.74e-05	0.000207	CcSEcCtD
Sildenafil—Hypoaesthesia—Doxorubicin—kidney cancer	3.74e-05	0.000206	CcSEcCtD
Sildenafil—Pharyngitis—Doxorubicin—kidney cancer	3.73e-05	0.000206	CcSEcCtD
Sildenafil—Paraesthesia—Capecitabine—kidney cancer	3.72e-05	0.000205	CcSEcCtD
Sildenafil—Hypersensitivity—Paclitaxel—kidney cancer	3.72e-05	0.000205	CcSEcCtD
Sildenafil—Urinary tract disorder—Doxorubicin—kidney cancer	3.71e-05	0.000205	CcSEcCtD
Sildenafil—Oedema peripheral—Doxorubicin—kidney cancer	3.7e-05	0.000204	CcSEcCtD
Sildenafil—Connective tissue disorder—Doxorubicin—kidney cancer	3.69e-05	0.000204	CcSEcCtD
Sildenafil—Dyspnoea—Capecitabine—kidney cancer	3.69e-05	0.000204	CcSEcCtD
Sildenafil—Urethral disorder—Doxorubicin—kidney cancer	3.68e-05	0.000203	CcSEcCtD
Sildenafil—Dyspepsia—Capecitabine—kidney cancer	3.64e-05	0.000201	CcSEcCtD
Sildenafil—Visual impairment—Doxorubicin—kidney cancer	3.62e-05	0.0002	CcSEcCtD
Sildenafil—Asthenia—Paclitaxel—kidney cancer	3.62e-05	0.0002	CcSEcCtD
Sildenafil—Decreased appetite—Capecitabine—kidney cancer	3.6e-05	0.000199	CcSEcCtD
Sildenafil—Nausea—Gemcitabine—kidney cancer	3.58e-05	0.000198	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Capecitabine—kidney cancer	3.57e-05	0.000197	CcSEcCtD
Sildenafil—Fatigue—Capecitabine—kidney cancer	3.57e-05	0.000197	CcSEcCtD
Sildenafil—Pruritus—Paclitaxel—kidney cancer	3.57e-05	0.000197	CcSEcCtD
Sildenafil—Erythema multiforme—Doxorubicin—kidney cancer	3.55e-05	0.000196	CcSEcCtD
Sildenafil—Pain—Capecitabine—kidney cancer	3.54e-05	0.000196	CcSEcCtD
Sildenafil—Constipation—Capecitabine—kidney cancer	3.54e-05	0.000196	CcSEcCtD
Sildenafil—Eye disorder—Doxorubicin—kidney cancer	3.51e-05	0.000194	CcSEcCtD
Sildenafil—Tinnitus—Doxorubicin—kidney cancer	3.5e-05	0.000193	CcSEcCtD
Sildenafil—Cardiac disorder—Doxorubicin—kidney cancer	3.48e-05	0.000193	CcSEcCtD
Sildenafil—Flushing—Doxorubicin—kidney cancer	3.48e-05	0.000193	CcSEcCtD
Sildenafil—Diarrhoea—Paclitaxel—kidney cancer	3.45e-05	0.000191	CcSEcCtD
Sildenafil—Feeling abnormal—Capecitabine—kidney cancer	3.41e-05	0.000188	CcSEcCtD
Sildenafil—Angiopathy—Doxorubicin—kidney cancer	3.41e-05	0.000188	CcSEcCtD
Sildenafil—Immune system disorder—Doxorubicin—kidney cancer	3.39e-05	0.000187	CcSEcCtD
Sildenafil—Gastrointestinal pain—Capecitabine—kidney cancer	3.38e-05	0.000187	CcSEcCtD
Sildenafil—Mediastinal disorder—Doxorubicin—kidney cancer	3.38e-05	0.000187	CcSEcCtD
Sildenafil—Chills—Doxorubicin—kidney cancer	3.37e-05	0.000186	CcSEcCtD
Sildenafil—Arrhythmia—Doxorubicin—kidney cancer	3.35e-05	0.000185	CcSEcCtD
Sildenafil—Dizziness—Paclitaxel—kidney cancer	3.33e-05	0.000184	CcSEcCtD
Sildenafil—Alopecia—Doxorubicin—kidney cancer	3.32e-05	0.000183	CcSEcCtD
Sildenafil—Mental disorder—Doxorubicin—kidney cancer	3.29e-05	0.000182	CcSEcCtD
Sildenafil—Urticaria—Capecitabine—kidney cancer	3.29e-05	0.000182	CcSEcCtD
Sildenafil—Body temperature increased—Capecitabine—kidney cancer	3.27e-05	0.000181	CcSEcCtD
Sildenafil—Abdominal pain—Capecitabine—kidney cancer	3.27e-05	0.000181	CcSEcCtD
Sildenafil—Malnutrition—Doxorubicin—kidney cancer	3.27e-05	0.000181	CcSEcCtD
Sildenafil—Erythema—Doxorubicin—kidney cancer	3.27e-05	0.000181	CcSEcCtD
Sildenafil—Flatulence—Doxorubicin—kidney cancer	3.22e-05	0.000178	CcSEcCtD
Sildenafil—Tension—Doxorubicin—kidney cancer	3.21e-05	0.000177	CcSEcCtD
Sildenafil—Vomiting—Paclitaxel—kidney cancer	3.21e-05	0.000177	CcSEcCtD
Sildenafil—Rash—Paclitaxel—kidney cancer	3.18e-05	0.000176	CcSEcCtD
Sildenafil—Dermatitis—Paclitaxel—kidney cancer	3.18e-05	0.000176	CcSEcCtD
Sildenafil—Nervousness—Doxorubicin—kidney cancer	3.17e-05	0.000175	CcSEcCtD
Sildenafil—Back pain—Doxorubicin—kidney cancer	3.16e-05	0.000175	CcSEcCtD
Sildenafil—Headache—Paclitaxel—kidney cancer	3.16e-05	0.000175	CcSEcCtD
Sildenafil—Vision blurred—Doxorubicin—kidney cancer	3.08e-05	0.00017	CcSEcCtD
Sildenafil—Hypersensitivity—Capecitabine—kidney cancer	3.05e-05	0.000168	CcSEcCtD
Sildenafil—Ill-defined disorder—Doxorubicin—kidney cancer	3.03e-05	0.000168	CcSEcCtD
Sildenafil—Anaemia—Doxorubicin—kidney cancer	3.02e-05	0.000167	CcSEcCtD
Sildenafil—Agitation—Doxorubicin—kidney cancer	3e-05	0.000166	CcSEcCtD
Sildenafil—Nausea—Paclitaxel—kidney cancer	3e-05	0.000166	CcSEcCtD
Sildenafil—Asthenia—Capecitabine—kidney cancer	2.97e-05	0.000164	CcSEcCtD
Sildenafil—Malaise—Doxorubicin—kidney cancer	2.95e-05	0.000163	CcSEcCtD
Sildenafil—Vertigo—Doxorubicin—kidney cancer	2.94e-05	0.000162	CcSEcCtD
Sildenafil—Syncope—Doxorubicin—kidney cancer	2.93e-05	0.000162	CcSEcCtD
Sildenafil—Pruritus—Capecitabine—kidney cancer	2.93e-05	0.000162	CcSEcCtD
Sildenafil—Leukopenia—Doxorubicin—kidney cancer	2.93e-05	0.000162	CcSEcCtD
Sildenafil—Palpitations—Doxorubicin—kidney cancer	2.89e-05	0.00016	CcSEcCtD
Sildenafil—Loss of consciousness—Doxorubicin—kidney cancer	2.87e-05	0.000159	CcSEcCtD
Sildenafil—Cough—Doxorubicin—kidney cancer	2.85e-05	0.000158	CcSEcCtD
Sildenafil—Convulsion—Doxorubicin—kidney cancer	2.83e-05	0.000156	CcSEcCtD
Sildenafil—Diarrhoea—Capecitabine—kidney cancer	2.83e-05	0.000156	CcSEcCtD
Sildenafil—Hypertension—Doxorubicin—kidney cancer	2.82e-05	0.000156	CcSEcCtD
Sildenafil—Myalgia—Doxorubicin—kidney cancer	2.78e-05	0.000154	CcSEcCtD
Sildenafil—Arthralgia—Doxorubicin—kidney cancer	2.78e-05	0.000154	CcSEcCtD
Sildenafil—Chest pain—Doxorubicin—kidney cancer	2.78e-05	0.000154	CcSEcCtD
Sildenafil—Anxiety—Doxorubicin—kidney cancer	2.77e-05	0.000153	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	2.76e-05	0.000153	CcSEcCtD
Sildenafil—Discomfort—Doxorubicin—kidney cancer	2.75e-05	0.000152	CcSEcCtD
Sildenafil—Dizziness—Capecitabine—kidney cancer	2.74e-05	0.000151	CcSEcCtD
Sildenafil—Dry mouth—Doxorubicin—kidney cancer	2.72e-05	0.00015	CcSEcCtD
Sildenafil—Oedema—Doxorubicin—kidney cancer	2.67e-05	0.000147	CcSEcCtD
Sildenafil—Infection—Doxorubicin—kidney cancer	2.65e-05	0.000146	CcSEcCtD
Sildenafil—Vomiting—Capecitabine—kidney cancer	2.63e-05	0.000145	CcSEcCtD
Sildenafil—Shock—Doxorubicin—kidney cancer	2.62e-05	0.000145	CcSEcCtD
Sildenafil—Nervous system disorder—Doxorubicin—kidney cancer	2.62e-05	0.000145	CcSEcCtD
Sildenafil—Rash—Capecitabine—kidney cancer	2.61e-05	0.000144	CcSEcCtD
Sildenafil—Dermatitis—Capecitabine—kidney cancer	2.61e-05	0.000144	CcSEcCtD
Sildenafil—Tachycardia—Doxorubicin—kidney cancer	2.6e-05	0.000144	CcSEcCtD
Sildenafil—Headache—Capecitabine—kidney cancer	2.59e-05	0.000143	CcSEcCtD
Sildenafil—Skin disorder—Doxorubicin—kidney cancer	2.59e-05	0.000143	CcSEcCtD
Sildenafil—Hyperhidrosis—Doxorubicin—kidney cancer	2.58e-05	0.000142	CcSEcCtD
Sildenafil—Anorexia—Doxorubicin—kidney cancer	2.54e-05	0.000141	CcSEcCtD
Sildenafil—Hypotension—Doxorubicin—kidney cancer	2.49e-05	0.000138	CcSEcCtD
Sildenafil—Nausea—Capecitabine—kidney cancer	2.46e-05	0.000136	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Doxorubicin—kidney cancer	2.43e-05	0.000134	CcSEcCtD
Sildenafil—Insomnia—Doxorubicin—kidney cancer	2.41e-05	0.000133	CcSEcCtD
Sildenafil—Paraesthesia—Doxorubicin—kidney cancer	2.4e-05	0.000132	CcSEcCtD
Sildenafil—Dyspnoea—Doxorubicin—kidney cancer	2.38e-05	0.000131	CcSEcCtD
Sildenafil—Somnolence—Doxorubicin—kidney cancer	2.37e-05	0.000131	CcSEcCtD
Sildenafil—Dyspepsia—Doxorubicin—kidney cancer	2.35e-05	0.00013	CcSEcCtD
Sildenafil—Decreased appetite—Doxorubicin—kidney cancer	2.32e-05	0.000128	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Doxorubicin—kidney cancer	2.3e-05	0.000127	CcSEcCtD
Sildenafil—Fatigue—Doxorubicin—kidney cancer	2.3e-05	0.000127	CcSEcCtD
Sildenafil—Constipation—Doxorubicin—kidney cancer	2.28e-05	0.000126	CcSEcCtD
Sildenafil—Pain—Doxorubicin—kidney cancer	2.28e-05	0.000126	CcSEcCtD
Sildenafil—Feeling abnormal—Doxorubicin—kidney cancer	2.2e-05	0.000121	CcSEcCtD
Sildenafil—Gastrointestinal pain—Doxorubicin—kidney cancer	2.18e-05	0.000121	CcSEcCtD
Sildenafil—Urticaria—Doxorubicin—kidney cancer	2.12e-05	0.000117	CcSEcCtD
Sildenafil—Abdominal pain—Doxorubicin—kidney cancer	2.11e-05	0.000117	CcSEcCtD
Sildenafil—Body temperature increased—Doxorubicin—kidney cancer	2.11e-05	0.000117	CcSEcCtD
Sildenafil—Hypersensitivity—Doxorubicin—kidney cancer	1.97e-05	0.000109	CcSEcCtD
Sildenafil—Asthenia—Doxorubicin—kidney cancer	1.91e-05	0.000106	CcSEcCtD
Sildenafil—Pruritus—Doxorubicin—kidney cancer	1.89e-05	0.000104	CcSEcCtD
Sildenafil—Diarrhoea—Doxorubicin—kidney cancer	1.83e-05	0.000101	CcSEcCtD
Sildenafil—Dizziness—Doxorubicin—kidney cancer	1.76e-05	9.75e-05	CcSEcCtD
Sildenafil—Vomiting—Doxorubicin—kidney cancer	1.7e-05	9.37e-05	CcSEcCtD
Sildenafil—Rash—Doxorubicin—kidney cancer	1.68e-05	9.29e-05	CcSEcCtD
Sildenafil—Dermatitis—Doxorubicin—kidney cancer	1.68e-05	9.29e-05	CcSEcCtD
Sildenafil—Headache—Doxorubicin—kidney cancer	1.67e-05	9.23e-05	CcSEcCtD
Sildenafil—Nausea—Doxorubicin—kidney cancer	1.58e-05	8.76e-05	CcSEcCtD
Sildenafil—CYP2C9—Metabolism—CA2—kidney cancer	9.63e-06	0.000193	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PSMD7—kidney cancer	9.49e-06	0.00019	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ALAD—kidney cancer	9.47e-06	0.00019	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PGK1—kidney cancer	9.42e-06	0.000189	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—SLC5A3—kidney cancer	9.42e-06	0.000189	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ALAD—kidney cancer	9.39e-06	0.000188	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—MAPK3—kidney cancer	9.38e-06	0.000188	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ST3GAL2—kidney cancer	9.24e-06	0.000185	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—LDHB—kidney cancer	9.24e-06	0.000185	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—POMC—kidney cancer	9.23e-06	0.000185	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PDHB—kidney cancer	9.17e-06	0.000184	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ST3GAL2—kidney cancer	9.16e-06	0.000184	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IGF2—kidney cancer	9.14e-06	0.000183	CbGpPWpGaD
Sildenafil—CYP3A4—Biological oxidations—POMC—kidney cancer	9.14e-06	0.000183	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CDKN2B—kidney cancer	9.1e-06	0.000182	CbGpPWpGaD
Sildenafil—ABCC5—Disease—RAF1—kidney cancer	9.09e-06	0.000182	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ALDH1A1—kidney cancer	9.04e-06	0.000181	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—BCHE—kidney cancer	9e-06	0.00018	CbGpPWpGaD
Sildenafil—ABCC5—Disease—ERBB2—kidney cancer	8.99e-06	0.00018	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—VEGFA—kidney cancer	8.98e-06	0.00018	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ALDH1A1—kidney cancer	8.96e-06	0.000179	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—MAPK1—kidney cancer	8.92e-06	0.000179	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—SLC5A5—kidney cancer	8.89e-06	0.000178	CbGpPWpGaD
Sildenafil—ABCC5—Disease—MTOR—kidney cancer	8.87e-06	0.000178	CbGpPWpGaD
Sildenafil—ABCC5—Disease—CD4—kidney cancer	8.86e-06	0.000177	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IGF1R—kidney cancer	8.84e-06	0.000177	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CRABP1—kidney cancer	8.83e-06	0.000177	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CRABP1—kidney cancer	8.81e-06	0.000176	CbGpPWpGaD
Sildenafil—ABCC5—Disease—PTGS2—kidney cancer	8.79e-06	0.000176	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PGK1—kidney cancer	8.66e-06	0.000174	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—SLC5A3—kidney cancer	8.66e-06	0.000174	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CCBL1—kidney cancer	8.62e-06	0.000173	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PGK1—kidney cancer	8.59e-06	0.000172	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—SLC5A3—kidney cancer	8.59e-06	0.000172	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—SLC2A1—kidney cancer	8.58e-06	0.000172	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—RAF1—kidney cancer	8.52e-06	0.000171	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—LDHB—kidney cancer	8.49e-06	0.00017	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—MAPK3—kidney cancer	8.49e-06	0.00017	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—KRAS—kidney cancer	8.43e-06	0.000169	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—LDHB—kidney cancer	8.42e-06	0.000169	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—IL2—kidney cancer	8.41e-06	0.000168	CbGpPWpGaD
Sildenafil—ABCC5—Disease—CDKN1B—kidney cancer	8.33e-06	0.000167	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CRABP1—kidney cancer	8.32e-06	0.000167	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—MYC—kidney cancer	8.26e-06	0.000166	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ITPR2—kidney cancer	8.2e-06	0.000164	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ITPR2—kidney cancer	8.19e-06	0.000164	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—MAPK1—kidney cancer	8.08e-06	0.000162	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CA9—kidney cancer	8.01e-06	0.00016	CbGpPWpGaD
Sildenafil—ABCC5—Disease—CTNNB1—kidney cancer	7.87e-06	0.000158	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	7.83e-06	0.000157	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—PIK3CA—kidney cancer	7.74e-06	0.000155	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ITPR2—kidney cancer	7.74e-06	0.000155	CbGpPWpGaD
Sildenafil—ABCC5—Disease—PTEN—kidney cancer	7.67e-06	0.000154	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—IL2—kidney cancer	7.64e-06	0.000153	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—KRAS—kidney cancer	7.63e-06	0.000153	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—TP53—kidney cancer	7.49e-06	0.00015	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ACHE—kidney cancer	7.48e-06	0.00015	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GSTT1—kidney cancer	7.48e-06	0.00015	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PPAT—kidney cancer	7.47e-06	0.00015	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GLIPR1—kidney cancer	7.47e-06	0.00015	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GSTT1—kidney cancer	7.47e-06	0.00015	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ACHE—kidney cancer	7.47e-06	0.00015	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CA9—kidney cancer	7.37e-06	0.000148	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PTGS2—kidney cancer	7.36e-06	0.000147	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CA9—kidney cancer	7.3e-06	0.000146	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—HIF1A—kidney cancer	7.28e-06	0.000146	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TSC2—kidney cancer	7.26e-06	0.000145	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—GSTP1—kidney cancer	7.16e-06	0.000143	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	7.14e-06	0.000143	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.13e-06	0.000143	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—SCARB1—kidney cancer	7.08e-06	0.000142	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—SCARB1—kidney cancer	7.07e-06	0.000142	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ACHE—kidney cancer	7.05e-06	0.000141	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GSTT1—kidney cancer	7.05e-06	0.000141	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—PIK3CA—kidney cancer	7.01e-06	0.00014	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PTGS1—kidney cancer	7.01e-06	0.00014	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PTGS1—kidney cancer	7e-06	0.00014	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—KDR—kidney cancer	6.96e-06	0.000139	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—FH—kidney cancer	6.95e-06	0.000139	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—APRT—kidney cancer	6.95e-06	0.000139	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PSMD7—kidney cancer	6.88e-06	0.000138	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PSMD7—kidney cancer	6.86e-06	0.000137	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CRABP1—kidney cancer	6.81e-06	0.000136	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—TP53—kidney cancer	6.79e-06	0.000136	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—ABCB1—kidney cancer	6.78e-06	0.000136	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—SCARB1—kidney cancer	6.68e-06	0.000134	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PTGS1—kidney cancer	6.61e-06	0.000132	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—GSTM1—kidney cancer	6.58e-06	0.000132	CbGpPWpGaD
Sildenafil—ABCC5—Disease—MAPK3—kidney cancer	6.55e-06	0.000131	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GPC3—kidney cancer	6.53e-06	0.000131	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—BCHE—kidney cancer	6.52e-06	0.000131	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—BCHE—kidney cancer	6.5e-06	0.00013	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PSMD7—kidney cancer	6.48e-06	0.00013	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—SLC5A5—kidney cancer	6.44e-06	0.000129	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—SLC5A5—kidney cancer	6.43e-06	0.000129	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PTEN—kidney cancer	6.42e-06	0.000129	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—APC—kidney cancer	6.41e-06	0.000128	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—KIT—kidney cancer	6.41e-06	0.000128	CbGpPWpGaD
Sildenafil—ABCC5—Disease—MYC—kidney cancer	6.37e-06	0.000128	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CA2—kidney cancer	6.35e-06	0.000127	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ITPR2—kidney cancer	6.33e-06	0.000127	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CRABP1—kidney cancer	6.26e-06	0.000125	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CYP1A1—kidney cancer	6.24e-06	0.000125	CbGpPWpGaD
Sildenafil—ABCC5—Disease—MAPK1—kidney cancer	6.23e-06	0.000125	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—SLC2A1—kidney cancer	6.22e-06	0.000125	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CRABP1—kidney cancer	6.21e-06	0.000124	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—SLC2A1—kidney cancer	6.21e-06	0.000124	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ALAD—kidney cancer	6.19e-06	0.000124	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—BCHE—kidney cancer	6.15e-06	0.000123	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—MAPK3—kidney cancer	6.14e-06	0.000123	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—POMC—kidney cancer	6.1e-06	0.000122	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—SLC5A5—kidney cancer	6.07e-06	0.000122	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ST3GAL2—kidney cancer	6.04e-06	0.000121	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—BRAF—kidney cancer	6.02e-06	0.000121	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ALDH1A1—kidney cancer	5.91e-06	0.000118	CbGpPWpGaD
Sildenafil—ABCC5—Disease—KRAS—kidney cancer	5.89e-06	0.000118	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—SLC2A1—kidney cancer	5.86e-06	0.000117	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—MAPK1—kidney cancer	5.84e-06	0.000117	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.84e-06	0.000117	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ITPR2—kidney cancer	5.82e-06	0.000117	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ACHE—kidney cancer	5.77e-06	0.000116	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GSTT1—kidney cancer	5.77e-06	0.000116	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ITPR2—kidney cancer	5.77e-06	0.000116	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.69e-06	0.000114	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PGK1—kidney cancer	5.66e-06	0.000113	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SLC5A3—kidney cancer	5.66e-06	0.000113	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—PIK3CA—kidney cancer	5.58e-06	0.000112	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—LDHB—kidney cancer	5.55e-06	0.000111	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—KRAS—kidney cancer	5.52e-06	0.000111	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—SCARB1—kidney cancer	5.46e-06	0.000109	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PTGS1—kidney cancer	5.41e-06	0.000108	CbGpPWpGaD
Sildenafil—ABCC5—Disease—PIK3CA—kidney cancer	5.41e-06	0.000108	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.32e-06	0.000107	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GSTT1—kidney cancer	5.31e-06	0.000106	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ACHE—kidney cancer	5.31e-06	0.000106	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PSMD7—kidney cancer	5.3e-06	0.000106	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ACHE—kidney cancer	5.26e-06	0.000105	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GSTT1—kidney cancer	5.26e-06	0.000105	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GSTP1—kidney cancer	5.19e-06	0.000104	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GSTP1—kidney cancer	5.18e-06	0.000104	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—PIK3CA—kidney cancer	5.07e-06	0.000102	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—RAF1—kidney cancer	5.03e-06	0.000101	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—BCHE—kidney cancer	5.03e-06	0.000101	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—SCARB1—kidney cancer	5.03e-06	0.000101	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—RELA—kidney cancer	5.01e-06	0.0001	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—SCARB1—kidney cancer	4.98e-06	9.98e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—ERBB2—kidney cancer	4.98e-06	9.97e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PTGS1—kidney cancer	4.98e-06	9.97e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—SLC5A5—kidney cancer	4.97e-06	9.95e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.96e-06	9.94e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PTGS1—kidney cancer	4.93e-06	9.88e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MTOR—kidney cancer	4.91e-06	9.84e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ABCB1—kidney cancer	4.91e-06	9.83e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ABCB1—kidney cancer	4.9e-06	9.81e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GSTP1—kidney cancer	4.89e-06	9.79e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PSMD7—kidney cancer	4.88e-06	9.77e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PSMD7—kidney cancer	4.84e-06	9.69e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CA9—kidney cancer	4.82e-06	9.65e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—SLC2A1—kidney cancer	4.8e-06	9.61e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GSTM1—kidney cancer	4.77e-06	9.55e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GSTM1—kidney cancer	4.76e-06	9.53e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.65e-06	9.32e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—POMC—kidney cancer	4.65e-06	9.32e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ABCB1—kidney cancer	4.63e-06	9.27e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—BCHE—kidney cancer	4.63e-06	9.27e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CDKN1B—kidney cancer	4.61e-06	9.23e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—BCHE—kidney cancer	4.59e-06	9.19e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—SLC5A5—kidney cancer	4.57e-06	9.15e-05	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PIK3CA—kidney cancer	4.53e-06	9.07e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—SLC5A5—kidney cancer	4.53e-06	9.07e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CYP1A1—kidney cancer	4.52e-06	9.05e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IL2—kidney cancer	4.51e-06	9.03e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CYP1A1—kidney cancer	4.51e-06	9.03e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GSTM1—kidney cancer	4.49e-06	9e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—SLC2A1—kidney cancer	4.41e-06	8.84e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CCND1—kidney cancer	4.4e-06	8.81e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—JUN—kidney cancer	4.39e-06	8.79e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—SLC2A1—kidney cancer	4.37e-06	8.76e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CTNNB1—kidney cancer	4.35e-06	8.72e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.24e-06	8.5e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PTEN—kidney cancer	4.24e-06	8.5e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CRABP1—kidney cancer	4.09e-06	8.2e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.06e-06	8.13e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GSTP1—kidney cancer	4e-06	8.02e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—VEGFA—kidney cancer	3.83e-06	7.68e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ITPR2—kidney cancer	3.81e-06	7.63e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ABCB1—kidney cancer	3.79e-06	7.59e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PTGS2—kidney cancer	3.71e-06	7.43e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.7e-06	7.41e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GSTP1—kidney cancer	3.68e-06	7.37e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GSTM1—kidney cancer	3.68e-06	7.37e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GSTP1—kidney cancer	3.65e-06	7.31e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MAPK3—kidney cancer	3.63e-06	7.26e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MYC—kidney cancer	3.53e-06	7.06e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.5e-06	7.01e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP1A1—kidney cancer	3.49e-06	6.98e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ABCB1—kidney cancer	3.48e-06	6.98e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ACHE—kidney cancer	3.47e-06	6.95e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTT1—kidney cancer	3.47e-06	6.95e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ABCB1—kidney cancer	3.45e-06	6.92e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MAPK1—kidney cancer	3.45e-06	6.91e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GSTM1—kidney cancer	3.38e-06	6.77e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—POMC—kidney cancer	3.37e-06	6.75e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—POMC—kidney cancer	3.36e-06	6.73e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GSTM1—kidney cancer	3.35e-06	6.72e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SCARB1—kidney cancer	3.29e-06	6.58e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—KRAS—kidney cancer	3.26e-06	6.53e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PTGS1—kidney cancer	3.25e-06	6.52e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PTEN—kidney cancer	3.23e-06	6.48e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP1A1—kidney cancer	3.21e-06	6.42e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PSMD7—kidney cancer	3.19e-06	6.39e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP1A1—kidney cancer	3.18e-06	6.37e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—POMC—kidney cancer	3.18e-06	6.36e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—BCHE—kidney cancer	3.02e-06	6.06e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PIK3CA—kidney cancer	2.99e-06	6e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SLC5A5—kidney cancer	2.99e-06	5.98e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TP53—kidney cancer	2.9e-06	5.8e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SLC2A1—kidney cancer	2.88e-06	5.78e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.86e-06	5.74e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PTGS2—kidney cancer	2.69e-06	5.38e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PTGS2—kidney cancer	2.68e-06	5.37e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.61e-06	5.23e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—POMC—kidney cancer	2.6e-06	5.21e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PTGS2—kidney cancer	2.53e-06	5.07e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTP1—kidney cancer	2.41e-06	4.82e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—POMC—kidney cancer	2.39e-06	4.79e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—POMC—kidney cancer	2.37e-06	4.75e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PTEN—kidney cancer	2.34e-06	4.69e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PTEN—kidney cancer	2.34e-06	4.68e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PIK3CA—kidney cancer	2.28e-06	4.57e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ABCB1—kidney cancer	2.28e-06	4.56e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTM1—kidney cancer	2.21e-06	4.43e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PTEN—kidney cancer	2.21e-06	4.43e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.1e-06	4.2e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PTGS2—kidney cancer	2.07e-06	4.15e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PTGS2—kidney cancer	1.91e-06	3.82e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PTGS2—kidney cancer	1.89e-06	3.79e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PTEN—kidney cancer	1.81e-06	3.62e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PTEN—kidney cancer	1.66e-06	3.33e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CA—kidney cancer	1.65e-06	3.31e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CA—kidney cancer	1.65e-06	3.3e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PTEN—kidney cancer	1.65e-06	3.3e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—POMC—kidney cancer	1.56e-06	3.13e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CA—kidney cancer	1.56e-06	3.12e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.28e-06	2.55e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PTGS2—kidney cancer	1.25e-06	2.5e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.17e-06	2.35e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.16e-06	2.33e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PTEN—kidney cancer	1.09e-06	2.18e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CA—kidney cancer	7.67e-07	1.54e-05	CbGpPWpGaD
